First-In-Human Study Of Camidanlumab Tesirine (Adct-301, Cami), An Anti-Cd25 Targeted Therapy In Patients (Pts) With Advanced Solid Tumours: Pharmacokinetics (Pk) And Biomarker Evaluation
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要